Columbia Select Large Cap Growth Fund Q3 2025 Commentary [Seeking Alpha]
Insmed, Inc. (INSM)
Last insmed, inc. earnings: 4/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insmed.com
Company Research
Source: Seeking Alpha
Our position in liquid cooling technology leader Vertiv was a relative outperformer in the industrials sector. In the health care sector, our holdings in biotechnology firms Argenx and Insmed both generated strong returns and added to relative results. In the consumer discretionary sector, our holdings in Chipotle Mexican Grill and online travel leader Booking Holdings declined in price and detracted from results. Andrii Dodonov/iStock via Getty Images Fund strategy Identifies companies that appear to be financially strong and growing earnings faster than the broader equity market Invests in 25–35 stocks that exhibit strength and growth potential, with no more than a 5% weighting This article was written by Quick Insights Underperformance stemmed from lagging software and consumer discretionary holdings, sector rotations, and not owning Apple, despite strong contributions from select industrial and health care names. The fund emphasizes durable secular growth, ove
Show less
Read more
Impact Snapshot
Event Time:
INSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed, Inc. news events
Weekly update
A roundup of the hottest topics
INSM
News
- Insmed (NASDAQ:INSM) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.MarketBeat
- Insmed (NASDAQ:INSM) was given a new $202.00 price target on by analysts at Truist Financial Corporation.MarketBeat
- INSM Stock Plummets on Sinus Study Failure, Adds New Pipeline Asset [Yahoo! Finance]Yahoo! Finance
- Mizuho's Jared Holz talks Insmed sinking double digits on sinus drug trial news [CNBC]CNBC
- Insmed (NASDAQ:INSM) had its price target lowered by analysts at TD Cowen from $269.00 to $241.00. They now have a "buy" rating on the stock.MarketBeat
INSM
Earnings
- 10/30/25 - Miss
INSM
Sec Filings
- 12/19/25 - Form 4
- 12/18/25 - Form 144
- 12/17/25 - Form 8-K
- INSM's page on the SEC website